Sorted RCC-41-PDX-2/CD133− and RCC-41-PDX-2/CD133+ (Figure 2B) shared the expression of equivalent high levels of OCT3/4, NANOG but they obviously differed in the expression of CD133 and EpCAM. This evidence concerns the gene NANOG and renal cell carcinoma.